Company · Markham, Ontario, Canada
Allergan Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 67
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 33
- 9 active
- Notices of Compliance
- 109
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BEZALIP SRStatus since Dec 2020 | 02083523 | Marketed | |
| SORIATANEStatus since Mar 2020 | 02070863 | Marketed | |
| SORIATANEStatus since Dec 2019 | 02070847 | Marketed | |
| ALBALON AStatus since Jul 2017 | 00433519 | Cancelled Post Market | |
| ALLERGAN EYE ITCH RELIEFStatus since Aug 2017 | 02302721 | Cancelled Pre Market | |
| ALOCRILStatus since Apr 2019 | 02241407 | Cancelled Post Market | |
| ANDRODERMStatus since Apr 2022 | 02239653 | Cancelled Post Market | |
| ANDRODERMStatus since Dec 2021 | 02245972 | Cancelled Post Market | |
| ASACOLStatus since Jul 2020 | 01997580 | Cancelled Post Market | |
| ASACOL 800Status since Jan 2021 | 02267217 | Cancelled Post Market | |
| BETAGAN 0.5% OPHTHALMIC SOLStatus since Feb 2020 | 00637661 | Cancelled Post Market | |
| BETAGAN OPH SOLN 0.25%Status since Jul 2017 | 00751286 | Cancelled Post Market | |
| BLEPH 10 DPSStatus since Aug 2011 | 00001287 | Cancelled Post Market | |
| BLEPHAMIDEStatus since Jan 2022 | 00807788 | Cancelled Post Market | |
| BLEPHAMIDE S.O.P.Status since Jul 2019 | 00307246 | Cancelled Post Market | |
| CELLUFRESH LIQ 0.5%Status since Jun 2000 | 01953826 | Cancelled Post Market | |
| CHLOROPTIC DPS 0.5%Status since Aug 2011 | 00001082 | Cancelled Post Market | |
| CHLOROPTIC OPH ONT 1%Status since Aug 2011 | 00001341 | Cancelled Post Market | |
| EPIFRIN 1%Status since Jan 2010 | 00001104 | Cancelled Post Market | |
| EPIFRIN 1/2%Status since Jan 2010 | 00001090 | Cancelled Post Market | |
| EPIFRIN 2%Status since Jan 2010 | 00001112 | Cancelled Post Market | |
| FIBRISTALStatus since Sep 2020 | 02408163 | Cancelled Post Market | |
| FML FORTE SUS 0.25%Status since Apr 2016 | 00707511 | Cancelled Post Market | |
| FML-NEO OPH SUSStatus since Aug 2011 | 00395153 | Cancelled Post Market | |
| GENERESSStatus since Jul 2021 | 02435659 | Cancelled Pre Market | |
| HERPLEXStatus since Aug 2011 | 00001120 | Cancelled Post Market | |
| HERPLEX DStatus since Aug 2011 | 00001317 | Cancelled Post Market | |
| HMSStatus since Aug 2011 | 00036676 | Cancelled Post Market | |
| LACRIL 0.5% DPSStatus since Aug 2011 | 00395900 | Cancelled Post Market | |
| LIQUIFILM FORTE 3%Status since Aug 2011 | 00368911 | Cancelled Post Market | |
| LIQUIFILM TEARSStatus since Aug 2011 | 00045616 | Cancelled Post Market | |
| LOESTRIN 1.5/30Status since Apr 2022 | 00297143 | Cancelled Post Market | |
| LOESTRIN 1.5/30Status since Jan 2022 | 00353027 | Cancelled Post Market | |
| LUMIGANStatus since Nov 2023 | 02245860 | Cancelled Post Market | |
| LUMIGAN PFStatus since Nov 2023 | 02400162 | Cancelled Pre Market | |
| MACROBIDStatus since Aug 2021 | 02063662 | Cancelled Post Market | |
| MEDIFLEX SOLUTIONStatus since Jul 2002 | 02230061 | Cancelled Post Market | |
| MINESTRIN 1/20Status since Apr 2022 | 00343838 | Cancelled Post Market | |
| MINESTRIN 1/20Status since Apr 2022 | 00315966 | Cancelled Post Market | |
| MIOGAN PWS 20MG/VIALStatus since Aug 2011 | 00784826 | Cancelled Post Market | |
| MIREZEStatus since Mar 2000 | 02230446 | Cancelled Post Market | |
| OCUFEN OPH SOLN 0.03%Status since Aug 2011 | 00766046 | Cancelled Post Market | |
| OMNICARE DISINFECTING SOLUTION 3%Status since Jul 2002 | 01918923 | Cancelled Post Market | |
| OPHTHETICStatus since Aug 2011 | 00001279 | Cancelled Post Market | |
| OPTICROMStatus since Jan 2019 | 02230621 | Cancelled Post Market | |
| OPTIFORM SOLUTIONStatus since Jul 2002 | 02230060 | Cancelled Post Market | |
| OXYTROLStatus since Nov 2022 | 02254735 | Cancelled Post Market | |
| POLYTRIM OPHTHALMIC SOLUTIONStatus since Oct 2022 | 02011956 | Cancelled Post Market | |
| PRED MILDStatus since Apr 2022 | 00299405 | Cancelled Post Market | |
| PREFRIN A LIQStatus since Jul 2012 | 00400408 | Cancelled Post Market | |
| PREFRIN LIQ 0.12%Status since Jul 2012 | 00395161 | Cancelled Post Market | |
| PRO-TEC SPORT LOTIONStatus since Aug 2011 | 02230150 | Cancelled Post Market | |
| PROBETA - LIQ OPHStatus since Jul 2012 | 02209071 | Cancelled Post Market | |
| PROPINE LIQ 0.1%Status since Aug 2011 | 00529117 | Cancelled Post Market | |
| RAPAFLOStatus since Dec 2021 | 02361663 | Cancelled Post Market | |
| RAPAFLOStatus since Nov 2022 | 02361671 | Cancelled Post Market | |
| REFRESH OPTIVEStatus since Dec 2023 | 02396858 | Cancelled Pre Market | |
| REFRESH OPTIVE FUSION SENSITIVEStatus since Jun 2024 | 02450534 | Cancelled Post Market | |
| REFRESH REDNESS RELIEFStatus since Nov 2022 | 02315920 | Cancelled Post Market | |
| REFRESH TRIAL PACK (REFRESH TEARS, REFRESH LIQUIGEL AND REFRESH ULTRA)Status since Jul 2017 | 02312662 | Cancelled Post Market | |
| SANCTURA XRStatus since Apr 2016 | 02339706 | Cancelled Post Market | |
| TAZORACStatus since Nov 2021 | 02230784 | Cancelled Post Market | |
| TAZORACStatus since Sep 2023 | 02230785 | Cancelled Post Market | |
| TAZORACStatus since Dec 2023 | 02243894 | Cancelled Post Market | |
| TAZORACStatus since Mar 2022 | 02243895 | Cancelled Post Market | |
| VISTACROM EYE OINTMENT 4%Status since Aug 1999 | 00803561 | Cancelled Post Market | |
| VISTACROM LIQ 2%Status since Aug 1997 | 00749478 | Cancelled Post Market |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| HARMONYCA LIDOCAINEFirst licensed Dec 2025 | 114447 | Issued (active) · Class 3 | |
| JUVÉDERM VOLUXFirst licensed Apr 2019 | 102650 | Issued (active) · Class 3 | |
| SKINVIVE BY JUVEDERMFirst licensed Feb 2018 | 100484 | Issued (active) · Class 3 | |
| XEN GLAUCOMA TREATMENT SYSTEMFirst licensed Feb 2015 | 94691 | Issued (active) · Class 3 | |
| JUVEDERM VOLIFT WITH LIDOCAINEFirst licensed Jul 2014 | 93534 | Issued (active) · Class 3 | |
| JUVEDERM VOLBELLA WITH LIDOCAINEFirst licensed Mar 2013 | 90956 | Issued (active) · Class 3 | |
| KELLER FUNNELFirst licensed Nov 2010 | 84351 | Issued (active) · Class 2 | |
| JUVEDERM VOLUMAFirst licensed Sep 2008 | 77899 | Issued (active) · Class 3 | |
| JUVEDERMFirst licensed Mar 2004 | 64039 | Issued (active) · Class 3 | |
| NATRELLE 410 TRUFORM MICROCELL SILICONE-FILLED BREAST IMPLANTSFirst licensed Jun 2018 | 101233 | Discontinued at renewal · Class 4 | |
| NATRELLE INSPIRA TRUFORM 1 MICROCELL BREAST IMPLANTSFirst licensed Jun 2018 | 101234 | Discontinued at renewal · Class 4 | |
| NATRELLE INSPIRA TRUFORM 2 MICROCELL BREAST IMPLANTSFirst licensed Jun 2018 | 101236 | Discontinued at renewal · Class 4 | |
| NATRELLE INSPIRA TRUFORM 1 (RESPONSIVE) BREAST IMPLANT (TEXTURED SHELL)First licensed Sep 2011 | 87277 | Suspended · Class 4 | |
| NATRELLE INSPIRA TRUFORM 2 (SOFT TOUCH) BREAST IMPLANT (TEXTURED SHELL)First licensed Sep 2011 | 87279 | Suspended · Class 4 | |
| NATRELLE 150 BREAST IMPLANTFirst licensed Jan 2011 | 84856 | Discontinued at renewal · Class 4 | |
| BREAST PROSTHESIS FILL TUBE PLUG KITFirst licensed Jan 2011 | 84862 | Discontinued at renewal · Class 4 | |
| NATRELLE 410 TRUFORM SILICONE - FILLED BREAST IMPLANTSFirst licensed Oct 2006 | 72262 | Suspended · Class 4 | |
| NATRELLE SILICONE - FILLED BREAST IMPLANTS - BIOCELL ROUNDFirst licensed Oct 2006 | 72263 | Suspended · Class 4 | |
| NATRELLE SILICONE SIZERFirst licensed Dec 2003 | 63400 | Cancelled · Class 2 | |
| COSMODERM/COSMOPLAST INJECTABLE COLLAGEN IMPLANTSFirst licensed Dec 2002 | 61173 | Cancelled · Class 4 | |
| NATRELLE 133 TISSUE EXPANDERFirst licensed Nov 2002 | 60887 | Cancelled · Class 4 | |
| SEP-TUM BOWEL RETRACTORFirst licensed Nov 2000 | 24780 | Discontinued at renewal · Class 2 | |
| ZYPLAST COLLAGEN IMPLANT WITH SYRINGEFirst licensed Dec 1999 | 14875 | Cancelled · Class 4 | |
| ZYDERM 2 COLLAGEN IMPLANT WITH SYRINGEFirst licensed Dec 1999 | 14881 | Cancelled · Class 4 | |
| ZYDERM I COLLAGEN IMPLANT WITH SYRINGEFirst licensed Nov 1999 | 13833 | Cancelled · Class 4 | |
| REMOTE ACCESS PORT FOR USE WITH TISSUE EXPANDERSFirst licensed Oct 1999 | 13651 | Cancelled · Class 4 | |
| VERSAFIL LOW PROFILE TISSUE EXPANDERFirst licensed Oct 1999 | 13652 | Cancelled · Class 4 | |
| STANDARD TISSUE EXPANDERFirst licensed Oct 1999 | 13556 | Cancelled · Class 4 | |
| SOFTFORM FACIAL IMPLANTFirst licensed Aug 1999 | 9181 | Discontinued at renewal · Class 3 | |
| NATRELLE SALINE-FILLED BREAST IMPLANTS (TEXTURED)First licensed May 1999 | 3112 | Suspended · Class 4 | |
| SMOOTH TISSUE EXPANDERS (MAGNA-SITE AND REMOTE INJECTION SITE)First licensed May 1999 | 3113 | Cancelled · Class 4 | |
| ENDOLUMINA II TRANSILLUMINATION SYSTEMFirst licensed May 1999 | 3279 | Discontinued at renewal · Class 2 | |
| SPECIALTY NEEDLESFirst licensed May 1999 | 3308 | Cancelled · Class 2 |
Notices of Compliance
Newest first.
- SORIATANEApril 4, 2025 · NOC 35129 · Supplement to a New Drug Submission (SNDS)
- VIBERZIOctober 15, 2024 · NOC 34195 · Supplement to a New Drug Submission (SNDS)
- ACUVAILSeptember 16, 2022 · NOC 28995 · Supplement to a New Drug Submission (SNDS)
- ACULAR; ACULAR LSAugust 26, 2022 · NOC 28836 · Supplement to a New Drug Submission (SNDS)
- BYSTOLICAugust 10, 2022 · NOC 28738 · Supplement to a New Drug Submission (SNDS)
- CONSTELLAJuly 26, 2022 · NOC 28657 · Supplement to a New Drug Submission (SNDS)
- ALPHAGANJuly 14, 2022 · NOC 28599 · Supplement to a New Drug Submission (SNDS)
- COMBIGANJuly 8, 2022 · NOC 28600 · Supplement to a New Drug Submission (SNDS)
- ACTONEL; ACTONEL DRJuly 5, 2022 · NOC 28520 · Supplement to a New Drug Submission (SNDS)
- ALPHAGAN PJune 22, 2022 · NOC 28447 · Supplement to a New Drug Submission (SNDS)
- BELKYRAJune 20, 2022 · NOC 28430 · Supplement to a New Drug Submission (SNDS)
- RESTASISMay 24, 2022 · NOC 28236 · Supplement to a New Drug Submission (SNDS)
- BOTOX, BOTOX COSMETICMay 24, 2022 · NOC 28247 · Supplement to a New Drug Submission (SNDS)
- VRAYLARApril 22, 2022 · NOC 28008 · New Drug Submission (NDS)
- ZYMARMarch 11, 2022 · NOC 27744 · Supplement to a New Drug Submission (SNDS)
- LUMIGAN RCFebruary 24, 2022 · NOC 27665 · Supplement to a New Drug Submission (SNDS)
- OCUFLOXFebruary 3, 2022 · NOC 27532 · Supplement to a New Drug Submission (SNDS)
- LATISSEDecember 2, 2021 · NOC 27158 · Supplement to a New Drug Submission (SNDS)
- BELKYRANovember 22, 2021 · NOC 27071 · New Drug Submission (NDS)
- FETZIMANovember 22, 2021 · NOC 27075 · Supplement to a New Drug Submission (SNDS)
- ASACOLMarch 19, 2021 · NOC 25487 · Supplement to a New Drug Submission (SNDS)
- ASACOL 800March 19, 2021 · NOC 25488 · Supplement to a New Drug Submission (SNDS)
- BOTOXMarch 11, 2021 · NOC 25425 · Supplement to a New Drug Submission (SNDS)
- VIIBRYDMarch 5, 2021 · NOC 25354 · Supplement to a New Drug Submission (SNDS)
- LOLONovember 17, 2020 · NOC 24607 · Supplement to a New Drug Submission (SNDS)
- ALPHAGAN PAugust 25, 2020 · NOC 24108 · Supplement to a New Drug Submission (SNDS)
- GENERESSJanuary 31, 2020 · NOC 23166 · New Drug Submission (NDS)
- BOTOX / BOTOX COSMETICJanuary 21, 2020 · NOC 23264 · Supplement to a New Drug Submission (SNDS)
- FETZIMANovember 15, 2019 · NOC 22911 · Supplement to a New Drug Submission (SNDS)
- BEZALIP SRNovember 1, 2019 · NOC 22851 · New Drug Submission (NDS)
- OZURDEXJuly 22, 2019 · NOC 22437 · Supplement to a New Drug Submission (SNDS)
- OPTICROMJuly 5, 2019 · NOC 22371 · Supplement to a New Drug Submission (SNDS)
- BOTOXJune 7, 2019 · NOC 22255 · Supplement to a New Drug Submission (SNDS)
- VIBERZIApril 29, 2019 · NOC 22113 · New Drug Submission (NDS)
- ACTONEL; ACTONEL DRMarch 15, 2019 · NOC 21979 · New Drug Submission (NDS)
- MINESTRIN 1/20March 1, 2019 · NOC 21913 · New Drug Submission (NDS)
- VIIBRYDJanuary 24, 2019 · NOC 21789 · New Drug Submission (NDS)
- LOESTRIN 1.5/30January 15, 2019 · NOC 21743 · New Drug Submission (NDS)
- FIBRISTALDecember 20, 2018 · NOC 21655 · Supplement to a New Drug Submission (SNDS)
- MACROBIDOctober 17, 2018 · NOC 21442 · New Drug Submission (NDS)
- BOTOXOctober 16, 2018 · NOC 21418 · Supplement to a New Drug Submission (SNDS)
- BYSTOLICOctober 5, 2018 · NOC 21394 · New Drug Submission (NDS)
- FETZIMASeptember 14, 2018 · NOC 21316 · New Drug Submission (NDS)
- CONSTELLAAugust 28, 2018 · NOC 21249 · New Drug Submission (NDS)
- SORIATANEAugust 10, 2018 · NOC 21200 · New Drug Submission (NDS)
- FIBRISTALJuly 30, 2018 · NOC 21160 · New Drug Submission (NDS)
- LOLOJuly 11, 2018 · NOC 21084 · New Drug Submission (NDS)
- RESTASIS MULTIDOSEJune 1, 2018 · NOC 20929 · New Drug Submission (NDS)
- ASACOLMarch 29, 2018 · NOC 20687 · New Drug Submission (NDS)
- ASACOL 800March 26, 2018 · NOC 20657 · New Drug Submission (NDS)
- OXYTROLMarch 19, 2018 · NOC 20638 · New Drug Submission (NDS)
- RAPAFLOMarch 12, 2018 · NOC 20605 · New Drug Submission (NDS)
- ANDRODERMFebruary 28, 2018 · NOC 20536 · New Drug Submission (NDS)
- OPTICROMFebruary 16, 2018 · NOC 20493 · Supplement to a New Drug Submission (SNDS)
- BOTOXMarch 1, 2017 · NOC 19012 · Supplement to a New Drug Submission (SNDS)
- ACULAR; ACULAR LSJuly 14, 2015 · NOC 17082 · Supplement to a New Drug Submission (SNDS)
- OZURDEXApril 16, 2015 · NOC 16865 · Supplement to a New Drug Submission (SNDS)
- RESTASISJune 2, 2014 · NOC 15673 · Supplement to a New Drug Submission (SNDS)
- BOTOXOctober 10, 2013 · NOC 14812 · Supplement to a New Drug Submission (SNDS)
- LUMIGAN PFFebruary 20, 2013 · NOC 14147 · Supplement to a New Drug Submission (SNDS)
- COMBIGANSeptember 18, 2012 · NOC 13660 · Supplement to a New Drug Submission (SNDS)
- OZURDEXJanuary 19, 2012 · NOC 12945 · Supplement to a New Drug Submission (SNDS)
- BOTOXDecember 21, 2011 · NOC 12882 · Supplement to a New Drug Submission (SNDS)
- BOTOXOctober 18, 2011 · NOC 12711 · Supplement to a New Drug Submission (SNDS)
- BOTOXJune 30, 2011 · NOC 12471 · Supplement to a New Drug Submission (SNDS)
- BOTOX COSMETICJune 30, 2011 · NOC 12472 · Supplement to a New Drug Submission (SNDS)
- ACUVAILJune 15, 2011 · NOC 12432 · New Drug Submission (NDS)
- OZURDEXFebruary 10, 2011 · NOC 12057 · New Drug Submission (NDS)
- RESTASISAugust 19, 2010 · NOC 11673 · New Drug Submission (NDS)
- LATISSEMay 5, 2010 · NOC 11351 · New Drug Submission (NDS)
- SANCTURA XRJanuary 15, 2010 · NOC 10939 · New Drug Submission (NDS)
- LUMIGAN RCSeptember 24, 2009 · NOC 10611 · Supplement to a New Drug Submission (SNDS)
- LUMIGAN 0.01%April 15, 2009 · NOC 10151 · Supplement to a New Drug Submission (SNDS)
- ACZONENovember 4, 2008 · NOC 9868 · New Drug Submission (NDS)
- BOTOXAugust 26, 2008 · NOC 9736 · Supplement to a New Drug Submission (SNDS)
- BOTOX COSMETICAugust 26, 2008 · NOC 9737 · Supplement to a New Drug Submission (SNDS)
- LUMIGANJanuary 2, 2008 · NOC 9270 · Supplement to a New Drug Submission (SNDS)
- ALLERGAN EYE ITCH RELIEFNovember 30, 2007 · NOC 9214 · New Drug Submission (NDS)
- COMBIGANAugust 24, 2007 · NOC 8992 · Supplement to a New Drug Submission (SNDS)
- BOTOX COSMETICNovember 4, 2005 · NOC 7593 · Supplement to a New Drug Submission (SNDS)
- CROWN-TIMNovember 29, 2004 · NOC 5931 · Abbreviated New Drug Submission (ANDS)
- ZYMARAugust 30, 2004 · NOC 5314 · New Drug Submission (NDS)
- ACULAR LSJanuary 12, 2004 · NOC 109 · Supplement to a New Drug Submission (SNDS)
- COMBIGANDecember 9, 2003 · NOC 125 · New Drug Submission (NDS)
- CROWN AK-TOBRADecember 2, 2003 · NOC 3592 · Abbreviated New Drug Submission (ANDS)
- ALPHAGAN PNovember 4, 2003 · NOC 151 · Supplement to a New Drug Submission (SNDS)
- BOTOX COSMETICAugust 22, 2003 · NOC 167 · Supplement to a New Drug Submission (SNDS)
- BOTOXAugust 22, 2003 · NOC 171 · Supplement to a New Drug Submission (SNDS)
- TAZORACJune 5, 2002 · NOC 841 · Supplement to a New Drug Submission (SNDS)
- LUMIGANMay 24, 2002 · NOC 325 · New Drug Submission (NDS)
- TAZORACMay 15, 2002 · NOC 843 · Supplement to a New Drug Submission (SNDS)
- BOTOXOctober 24, 2001 · NOC 1705 · Supplement to a New Drug Submission (SNDS)
- BOTOXAugust 31, 2001 · NOC 1723 · Supplement to a New Drug Submission (SNDS)
- TAZORACMay 30, 2001 · NOC 2640 · Supplement to a New Drug Submission (SNDS)
- BOTOX COSMETICApril 4, 2001 · NOC 1735 · Supplement to a New Drug Submission (SNDS)
- ALOCRILAugust 25, 2000 · NOC 1344 · Supplement to a New Drug Submission (SNDS)
- ALOCRILDecember 17, 1999 · NOC 1942 · Supplement to a New Drug Submission (SNDS)
- BOTOXJuly 7, 1999 · NOC 1609 · Supplement to a New Drug Submission (SNDS)
- BOTOXMay 14, 1999 · NOC 1612 · Supplement to a New Drug Submission (SNDS)
- BOTOXJanuary 16, 1998 · NOC 2737 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 109.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver InjurySeptember 30, 2020 · Drugs · Product safety
- Fibristal 5MG (2020-09-24)September 24, 2020 · Drugs · Product safety · Type II
- JUVEDERM ULTRA 4 (COUNTERFEITED) (2015-03-07)April 13, 2015 · Medical devices · Health products · Type II
- Asacol 800 (2013-11-27)December 9, 2013 · Drugs · Product safety · Type III